Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AOTI, Inc. ( (GB:AOTI) ) has provided an update.
AOTI, Inc. announced that its Non-executive Chairman, Mr. Douglas Lefort, and his spouse transferred a total of 149,895 common shares into their Self-Invested Personal Pensions (SIPPs) from their consulting vehicle, Wolfpack Consulting Limited. This transaction, conducted on May 1, 2025, does not alter Mr. Lefort’s beneficial holding in the company, which remains at 1,451,621 shares, representing 1.36% of the company’s issued share capital. The move is part of routine financial management and does not impact the company’s operations or market position.
More about AOTI, Inc.
AOTI, Inc., founded in 2006 and based in Oceanside, California, US, and Galway, Ireland, specializes in innovative solutions for severe and chronic wound care. The company’s flagship product, the non-invasive Topical Wound Oxygen (TWO2®) Therapy, has been shown to significantly reduce the recurrence of Diabetic Foot Ulcers and associated hospitalizations and amputations, with regulatory approvals in multiple countries.
YTD Price Performance: -27.93%
Average Trading Volume: 38,000
Technical Sentiment Signal: Strong Buy
Current Market Cap: £85.09M
For an in-depth examination of AOTI stock, go to TipRanks’ Stock Analysis page.